On June 12, 2024, FOXO Technologies Inc., a Delaware corporation, entered into a Securities Purchase Agreement (SPA) with an institutional investor for the issuance of Senior Notes totaling up to $2,800,000. The agreement includes multiple closings, with the initial purchase amounting to $840,000 in principal amount of the Notes and an issuance of 1,108,755 shares of Class A Common Stock, representing 9.99% of the outstanding shares. Subsequent purchases are contingent upon specific milestones related to the company's acquisition of Rennova Community Health, Inc. and the filing of a registration statement for the resale of Class A Common Stock. The initial closing occurred on June 14, 2024, with the issuance of a Note in the principal amount of $840,000. The Note matures on June 14, 2025, and includes an original issuance discount of 12%. Rennova Health, Inc. guarantees the Note, and the issuance of shares is pending NYSE American approval. FOXO Technologies also announced the SPA and the Note issuance in a press release on June 18, 2024.

On June 12, 2024, FOXO Technologies Inc., a Delaware corporation, entered into a Securities Purchase Agreement (SPA) with an institutional investor for the issuance of Senior Notes totaling up to $2,800,000. The agreement includes multiple closings, with the initial purchase amounting to $840,000 in principal amount of the Notes and an issuance of 1,108,755 shares of Class A Common Stock, representing 9.99% of the outstanding shares. Subsequent purchases are contingent upon specific milestones related to the company's acquisition of Rennova Community Health, Inc. and the filing of a registration statement for the resale of Class A Common Stock. The initial closing occurred on June 14, 2024, with the issuance of a Note in the principal amount of $840,000. The Note matures on June 14, 2025, and includes an original issuance discount of 12%. Rennova Health, Inc. guarantees the Note, and the issuance of shares is pending NYSE American approval. FOXO Technologies also announced the SPA and the Note issuance in a press release on June 18, 2024.